Related references
Note: Only part of the references are listed.Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension
Ke Yuan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension
Yen-Rei A. Yu et al.
JOURNAL OF IMMUNOLOGY (2020)
CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension
Shariq Abid et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling
Bingbing Li et al.
HYPERTENSION (2019)
Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension
Zhongkai Zhu et al.
PULMONARY CIRCULATION (2019)
Hypoxia-inducible factor-1 α deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension
Hiroshi Kojima et al.
PHYSIOLOGICAL REPORTS (2019)
Pericyte ALK5/TIMP3 Axis Contributes to Endothelial Morphogenesis in the Developing Brain
Jui M. Dave et al.
DEVELOPMENTAL CELL (2018)
Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes
Jonathan Florentin et al.
JOURNAL OF IMMUNOLOGY (2018)
Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells
Ashish Misra et al.
NATURE COMMUNICATIONS (2018)
Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension
Abdul Q. Sheikh et al.
CELL REPORTS (2018)
Tunability of Biodegradable Poly(amine-co-ester) Polymers for Customized Nucleic Acid Delivery and Other Biomedical Applications
Amy C. Kauffman et al.
BIOMACROMOLECULES (2018)
Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation
Franziska G. Leifer et al.
DRUG RESEARCH (2018)
Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells
Jiajia Cui et al.
NATURE COMMUNICATIONS (2017)
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension
Rahul Kumar et al.
NATURE COMMUNICATIONS (2017)
Origin and production of inflammatory perivascular macrophages in pulmonary hypertension
Jonathan Florentin et al.
CYTOKINE (2017)
The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension
Mark R. Nicolls et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension
Valerie Amsellem et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
HIF2α-arginase axis is essential for the development of pulmonary hypertension
Andrew S. Cowburn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A global view of pulmonary hypertension
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2016)
Depletion of Alveolar Macrophages Attenuates Hypoxic Pulmonary Hypertension but not Hypoxia-Induced Increase in Serum Concentration of MCP-1
M. Zaloudikova et al.
PHYSIOLOGICAL RESEARCH (2016)
Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension
Henrik ten Freyhaus et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension
Jared M. McLendon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Encapsulation of beraprost sodium in nanoparticles: Analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension
Tomoaki Ishihara et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
Adaani E. Frost et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension
Abdul Q. Sheikh et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Regulation of Hypoxia-induced Pulmonary Hypertension by Vascular Smooth Muscle Hypoxia-Inducible Factor-1α
Molly K. Ball et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Development and pathologies of the arterial wall
Sara B. Seidelmann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Pulmonary Hypertension Surveillance United States, 2001 to 2010
Mary G. George et al.
CHEST (2014)
Embryonic and Adult-Derived Resident Cardiac Macrophages Are Maintained through Distinct Mechanisms at Steady State and during Inflammation
Slava Epelman et al.
IMMUNITY (2014)
Recapitulation of Developing Artery Muscularization in Pulmonary Hypertension
Abdul Q. Sheikh et al.
CELL REPORTS (2014)
Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
Wen Tian et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
Raymond L. Benza et al.
CHEST (2012)
Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary Hypertension
Eleni Vergadi et al.
CIRCULATION (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Platelet- derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
Maria J. Overbeek et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Macrophages: Master Regulators of Inflammation and Fibrosis
Thomas A. Wynn et al.
SEMINARS IN LIVER DISEASE (2010)
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension
Frederic Perros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3
Karl R. Karlsson et al.
EXPERIMENTAL HEMATOLOGY (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
The branching programme of mouse lung development
Ross J. Metzger et al.
NATURE (2008)
Macrophage β3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFα expression
Jochen G. Schneider et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A global double-fluorescent cre reporter mouse
Mandar Deepak Muzumdar et al.
GENESIS (2007)
Acute postnatal ablation of Hif-2α results in anemia
Michaela Gruber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tricuspid annular displacement predicts survival in pulmonary hypertension
Paul R. Forfia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Hypoxia-induced pulmonary vascular remodeling - Cellular and molecular mechanisms
Kurt R. Stenmark et al.
CIRCULATION RESEARCH (2006)
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
Micah R. Fisher et al.
ARTHRITIS AND RHEUMATISM (2006)
Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension
S Mahapatra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Dominant negative mutation of the TGF-β receptor blocks hypoxia-induced pulmonary vascular remodeling
YF Chen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases
RE Girgis et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus
V Balasubramaniam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy
M Enge et al.
EMBO JOURNAL (2002)
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor
VH Haase et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
